Affiliation:
1. Office for Internal Medicine, Gastroenterology, and Hepatology
2. Office for general and visceral surgery
3. Private biologist office
Abstract
Abstract
Background: Standard Helicobacter pylori eradication therapy is based on proton pump inhibitors and antibiotics. There are, however, important limitations: increasing antibiotic resistance of Helicobacter pylori, medical contraindications, and an increasing unwillingness among patients to use antibiotics.
Case presentations: We present three exemplary case reports of successful antibiotic-free Helicobacter pylorieradication therapies, one for each of these limiting categories: a 61-year-old female Caucasian patient refractory to prior eradication therapy, an 80-year-old female Caucasian patient with contraindication to antibiotics, and a 41-year-old male Caucasian patient refusing antibiotics. A review of the literature attempts to provide a scientific rationale for proton pump inhibitor-based and probiotics-supported Helicobacter pylorieradication.
Conclusion: Antibiotics-free Helicobacter pylorieradication may offer a therapeutic option for patients in whom classical eradication therapy cannot be conducted or who are refractory to antibiotics. Clinical trials are needed to scientifically evaluate the concept presented here.
Publisher
Research Square Platform LLC
Reference17 articles.
1. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication;Nyssen OP;Cochrane Database Syst Rev,2016
2. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report;Malfertheiner P;Gut,2017
3. [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease];Fischbach W;Z für Gastroenterologie,2016
4. Bundesamt für Sicherheit im Gesundheitswesen. : Summary of product characteristics: Pylera. https://aspregister.basg.gv.at/document/servlet?action=show&zulnr=135697-P1&type=DOTC_FACH_INFO (2019). Accessed 11 May 2021.
5. The life and death of Helicobacter pylori;Scott D;Gut,1998